Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, but are often symptom-free. Immunologists developed and tested nanoparticles containing gliadin for the immunomodulatory treatment of celiac disease.
from Diet and Weight Loss News -- ScienceDaily https://ift.tt/2uGQBa5
No comments:
Post a Comment